High levels of RSPO2 are detected in these tumours, whilst immunohistochemical analysis of HCC tumours harbouring RSPO2 mutations showed both strong nuclear β-catenin and glutamine synthetase staining, indicating a strong WNT pathway activation in these tumours [53]. Here, GLUL is linked to neoplasm.